Phase II trial of CCX168 in the patients with atypical hemolytic uremic syndrome

Trial Profile

Phase II trial of CCX168 in the patients with atypical hemolytic uremic syndrome

Planning
Phase of Trial: Phase II

Latest Information Update: 15 Jun 2017

At a glance

  • Drugs Avacopan (Primary)
  • Indications Haemolytic uraemic syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top